Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer’s Disease
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume -, Issue -, Pages 1-10
Publisher
IOS Press
Online
2019-03-20
DOI
10.3233/jad-181001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alzheimer's Disease-like Paired Helical Filament Assembly from Truncated Tau Protein Is Independent of Disulfide Crosslinking
- (2017) Youssra K. Al-Hilaly et al. JOURNAL OF MOLECULAR BIOLOGY
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
- (2016) Serge Gauthier et al. LANCET
- Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer’s disease treatment
- (2016) Wenchao Sun et al. Scientific Reports
- Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models
- (2015) Valeria Melis et al. BEHAVIOURAL PHARMACOLOGY
- The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease
- (2015) Heiko Braak et al. BRAIN
- Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups
- (2015) Yoshiyuki Soeda et al. Nature Communications
- Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers
- (2015) Catherine M. Cowan et al. Scientific Reports
- Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
- (2015) Katja Hochgräfe et al. Acta Neuropathologica Communications
- Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
- (2014) Cliona Stack et al. HUMAN MOLECULAR GENETICS
- Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia
- (2014) Casey Cook et al. NEUROBIOLOGY OF AGING
- “Tau Oligomers,” What We Know and What We Don’t Know
- (2014) Naruhiko Sahara et al. Frontiers in Neurology
- Mechanistic Basis of Phenothiazine-Driven Inhibition of Tau Aggregation
- (2013) Elias Akoury et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation
- (2013) Alex Crowe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult
- (2013) William I. Rosenblum NEUROBIOLOGY OF AGING
- Methylene blue induces macroautophagy through 5′ adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation
- (2013) Luokun Xie et al. Frontiers in Cellular Neuroscience
- The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
- (2013) R. Tarawneh et al. Cold Spring Harbor Perspectives in Medicine
- Hyperphosphorylation-Induced Tau Oligomers
- (2013) Khalid Iqbal et al. Frontiers in Neurology
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- The fuzzy coat of pathological human Tau fibrils is a two-layered polyelectrolyte brush
- (2012) Susanne Wegmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils
- (2011) Andra Noormägi et al. JOURNAL OF PEPTIDE SCIENCE
- TAU Aggregation is a Therapeutic Target for Alzheimers Disease
- (2010) A. Takashima Current Alzheimer Research
- Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss
- (2010) Tetsuya Kimura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds
- (2009) Sean A. Hudson et al. FEBS Journal
- Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
- (2009) U. K. Jinwal et al. JOURNAL OF NEUROSCIENCE
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine
- (2008) Serena Deiana et al. PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started